SAbR For Oligometastatic Renal Cell Carcinoma
Clinical trial NCT02956798 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02956798
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-19
- Primary completion
- 2025-12-30
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.